Exeter, United Kingdom

Nicholas Turner


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Nicholas Turner in Biotransformation

Introduction

Nicholas Turner is a notable inventor based in Exeter, GB. He has made significant contributions to the field of biochemistry, particularly in the preparation of amino acids through innovative methods. His work focuses on the enantiomeric forms of amino acids, which are crucial in various pharmaceutical applications.

Latest Patents

Turner's most recent patent is titled "Method for preparing tert-leucine and analogues thereof in enantiomeric form and intermediates therein." This patent describes a process where Azlactone undergoes biotransformation using suitable enzymatic activity. The method allows for the formation of a N-acyl-amino acid, which can be converted into amino acids with high enantiomeric excess. This innovation is significant for the synthesis of compounds that are essential in drug development.

Career Highlights

Nicholas Turner has been associated with Chirotech Technology Limited, where he has applied his expertise in biotransformation. His work has led to advancements in the production of amino acids, which are vital for various biochemical processes. With one patent to his name, he continues to push the boundaries of what is possible in the field of biochemistry.

Collaborations

Turner has collaborated with notable colleagues such as James Winterman and Raymond McCague. These partnerships have fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.

Conclusion

Nicholas Turner is a prominent figure in the field of biochemistry, known for his innovative methods in amino acid preparation. His contributions through patents and collaborations highlight the importance of teamwork in scientific advancements. His work continues to influence the pharmaceutical industry and the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…